Valid for Submission
I27.20 is a billable code used to specify a medical diagnosis of pulmonary hypertension, unspecified. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code I27.20 might also be used to specify conditions or terms like episodic pulmonary hypertension, hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome, precapillary pulmonary hypertension, progressive pulmonary hypertension, pulmonary arterial hypertension, pulmonary hypertension, etc
|Short Description:||Pulmonary hypertension, unspecified|
|Long Description:||Pulmonary hypertension, unspecified|
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code I27.20:
Inclusion Terms Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Pulmonary hypertension NOS
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code I27.20 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Episodic pulmonary hypertension
- Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
- Precapillary pulmonary hypertension
- Progressive pulmonary hypertension
- Pulmonary arterial hypertension
- Pulmonary hypertension
- Pulmonary hypertensive venous disease
- HYPERTENSION PULMONARY-. increased vascular resistance in the pulmonary circulation usually secondary to heart diseases or lung diseases.
- PERSISTENT FETAL CIRCULATION SYNDROME-. a syndrome of persistent pulmonary hypertension in the newborn infant infant newborn without demonstrable heart diseases. this neonatal condition can be caused by severe pulmonary vasoconstriction reactive type hypertrophy of pulmonary arterial muscle hypertrophic type or abnormally developed pulmonary arterioles hypoplastic type. the newborn patient exhibits cyanosis and acidosis due to the persistence of fetal circulatory pattern of right to left shunting of blood through a patent ductus arteriosus ductus arteriosus patent and at times a patent foramen ovale foramen ovale patent.
- FAMILIAL PRIMARY PULMONARY HYPERTENSION-. familial or idiopathic hypertension in the pulmonary circulation which is not secondary to other disease.
Diagnostic Related Groups
The ICD-10 code I27.20 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
- 314 - OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MCC
- 315 - OTHER CIRCULATORY SYSTEM DIAGNOSES WITH CC
- 316 - OTHER CIRCULATORY SYSTEM DIAGNOSES WITHOUT CC/MCC
I2720 replaces the following previously assigned ICD-10 code(s):
- I27.2 - Other secondary pulmonary hypertension
Convert I27.20 to ICD-9
- 416.8 - Chr pulmon heart dis NEC (Approximate Flag)
Diseases of the circulatory system (I00–I99)
Pulmonary heart disease and diseases of pulmonary circulation (I26-I28)
Other pulmonary heart diseases (I27)
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021